Tadalafil
- Product NDC
- 70518-2450
- 11-digit product format
- 705182450
- Labeler code
- 70518
- Product ID
- 70518-2450_c9495e71-c944-722a-e053-2a95a90aed50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206286
- Marketing category
- ANDA
- Marketing start
- 2019-11-25
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2450-0 | 70518245000 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2450-0) | 90 tablet | 2019-11-25 | 0000-00-00 | No | No | Current |
| 70518-2450-1 | 70518245001 | 12 TABLET in 1 BOTTLE, PLASTIC (70518-2450-1) | 12 tablet | 2020-02-04 | 0000-00-00 | No | No | Current |